Peptic Ulcer: all 194 studies

Page 2 of 2. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.

• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple TherapyCompletedNCT02633930Phase 4
• The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult VolunteersCompletedNCT02581696Phase 1
• Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent ClotCompletedNCT02536989Phase 4
• Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk PatientsCompletedNCT02456012Phase 4
• WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal EndoscopyStatus unknownNCT02436018Not applicable
• Doppler-guided Endoscopic Treatment in Peptic Ulcer BleedingStatus unknownNCT02434978Not applicable
• Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their OutcomesTerminatedNCT02352155Not applicable
• Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin UsersCompletedNCT02342470Phase 2
• Volatile Markers in Digestive CancerCompletedNCT02332213
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT02296021Phase 4
• DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic UlcersTerminatedNCT02262169Phase 3
• Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic UlcersCompletedNCT02245802
• Argon Plasma Coagulation for Bleeding Peptic UlcersCompletedNCT02241044Phase 4
• The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic UlcersCompletedNCT02197039
• Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori EradicationCompletedNCT02175901Phase 4
• Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionCompletedNCT02175186Phase 4
• Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCTCompletedNCT02166008Phase 2/3
• Frequent Ketamine Use and Gastrointestinal, Liver and Biliary SequelaeCompletedNCT02165488
• Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort StudyCompletedNCT02152904
• Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days TreatmentCompletedNCT02084420Phase 3
• Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer BleedingCompletedNCT02020603Not applicable
• HEP-FYN 12-Years Follow-upStatus unknownNCT02001727Not applicable
• Adverse Events During Upper Gastrointestinal EndoscopyStatus unknownNCT01979549
• Risk of Uncomplicated Peptic Ulcer in the General PopulationCompletedNCT01888588
• Prevention of Gastric Ulcer Bleeding by Using "Computer-alert" in General PracticeStatus unknownNCT01845168Not applicable
• Postoperative Oral Nutritional Supplementation After Major Gastrointestinal SurgeryCompletedNCT01838109Not applicable
• Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey ProteinCompletedNCT01828645Phase 2/3
• The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With HypoalbuminemiaCompletedNCT01822600Phase 4
• The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin UsersCompletedNCT01814943
• Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)CompletedNCT01675856Not applicable
• Empirical Rescue Therapies of Helicobacter Pylori InfectionCompletedNCT01668927Phase 4
• Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori TreatmentCompletedNCT01667718Phase 4
• Aizthromycin or Clarithromycin in H-pylori Eradication RegimenCompletedNCT01667692Phase 4
• Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.PyloriCompletedNCT01667575Phase 4
• Fast-track Surgery for Perforated Peptic UlcersCompletedNCT01620671Phase 4
• Helicobacter Pylori and the Long-term Risk of Peptic Ulcer BleedingCompletedNCT01591486
• The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic UlcersCompletedNCT01591083Phase 4
• Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal UlcersCompletedNCT01560702Not applicable
• Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical ProceduresCompletedNCT01524081Phase 3
• Prognostic Indicators as Provided by the EPIC ClearViewCompletedNCT01476995
• Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic TreatmentCompletedNCT01447498Not applicable
• H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency DepartmentCompletedNCT01376414
• Hemostasis of Active Gastrointestinal (GI) Luminal Tract BleedingCompletedNCT01306864Not applicable
• Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer BleedingCompletedNCT01282853Not applicable
• China Survey of Peptic Ulcer BleedingCompletedNCT01241266
• Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic HemostasisStatus unknownNCT01182597Phase 3
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding UlcersCompletedNCT01180179Phase 4
• Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic TherapyCompletedNCT01142245Phase 3
• Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic HemostasisCompletedNCT01142180Not applicable
• Supplementary Angiographic Embolization for Peptic Ulcer BleedingCompletedNCT01125852Not applicable
• Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)WithdrawnNCT01123031Phase 4
• Perforated Marginal Ulcer After Gastric BypassCompletedNCT01041196
• Chronic Marginal Ulcers After Gastric BypassCompletedNCT01041079
• Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric BypassCompletedNCT01040416
• Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyTerminatedNCT01015729Phase 1
• Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken SeparatelyCompletedNCT00998075Phase 1
• Drop in Gastroscopy - Experience After 9 MonthsCompletedNCT00977678
• Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal TractCompletedNCT00920400
• Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer RebleedingWithdrawnNCT00881413Phase 4
• Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump InhibitorStatus unknownNCT00854776Not applicable
• Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/ErosionCompletedNCT00843063Phase 4
• The Dissemination of Consensus Recommendations on Upper Gastrointestinal BleedingCompletedNCT00840008Phase 4
• Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal UlcersCompletedNCT00778193Phase 4
• TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic TherapyTerminatedNCT00766961Not applicable
• The LAMA Trial: Laparoscopic Correction of Perforated Peptic Ulcer Versus Open CorrectionCompletedNCT00745667Not applicable
• Intravenous Proton Pump Inhibitor for Peptic Ulcer BleedingCompletedNCT00731601Phase 4
• High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic TreatmentStatus unknownNCT00709046Not applicable
• Helicobacter Pylori Empiric Treatment in Ulcer BleedingStatus unknownNCT00687336Phase 4
• Peptic Ulcer Perforation StudyCompletedNCT00624169Not applicable
• Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy AdultsCompletedNCT00613665Phase 1
• Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding UlcersCompletedNCT00573924Not applicable
• Importance of Cytokines in Peptic Ulcer Disease: Implications for TreatmentCompletedNCT00534443Phase 4
• Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic UlcersCompletedNCT00519519Phase 3
• Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic UlcerStatus unknownNCT00471029Phase 4
• The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After AntrectomyStatus unknownNCT00441831
• High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer BleedingCompletedNCT00374101Phase 3
• AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy VolunteersCompletedNCT00325715Phase 1
• Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic UlcersCompletedNCT00279123Phase 4
• Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)CompletedNCT00261300Phase 3
• Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding UlcerWithdrawnNCT00247130Phase 4
• Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)CompletedNCT00212225
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCompletedNCT00175032Phase 3
• Resolution Endoclips Vs Epinephrine Injection and Heater ProbeTerminatedNCT00165009Phase 3
• A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic UlcerCompletedNCT00164931Phase 3
• Role of Doppler Ultrasound in Severe Peptic Ulcer HemorrhageTerminatedNCT00164905Not applicable
• Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to EndoscopyCompletedNCT00164866Phase 4
• Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule EndoscopyStatus unknownNCT00164827
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD RelationshipsStatus unknownNCT00162877Not applicable
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive MedicationStatus unknownNCT00161096Phase 3
• Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic UlcersCompletedNCT00153712
• Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal BleedingCompletedNCT00152399Phase 2
• Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy PopulationCompletedNCT00137033Phase 4
• Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00040495Phase 3
• Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageCompletedNCT00037570Phase 2

← Peptic Ulcer overview